Sponsor Pipeline

Immunome, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Phase 3
6
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT06823167
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer		 Enrollment increased: 117 -> 190 participants
2026-08-11 NCT06823167
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer		 Trial arms changed: 1 -> 2
2026-07-19 NCT07505771
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer		 Trial arms changed: 1 -> 2
Active Trials by Phase
Phase 2/3
1
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT04871282 A Study of AL102 in Patients With Progressing Desmoid Tumors Desmoid Active, Not Recruiting
Phase 1
NCT07610005 A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy… Healthy Recruiting
NCT07578571 A Phase 1 Study of IM-1617 in Participants With Advanced Cancer Colorectal Cancer Recruiting
NCT06823167 A Phase 1 Study of IM-1021 in Participants With Advanced Cancer Solid Malignancies Recruiting
Early Phase 1
NCT07505771 A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer Solid Malignancies Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Gastric Cancer (1) Esophageal Cancer (1)
Get alerts when Immunome, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free